This inventor holds 7 USPTO granted patents and 1 published patent application, plus 3 CIPO patents and 2 EPO patents. Top assignee: Mannkind Corporation. Active years: 2013-2025.
Company Filing History:
Years Active: 2013-2025
Title: Edwin Amoro: Innovator in Pharmaceutical Cryogranulation
Introduction
Edwin Amoro is a notable inventor based in West Haven, CT (US), recognized for his contributions to the field of pharmaceutical technology. With a total of 7 patents, he has made significant advancements in the methods and apparatus used for cryogranulating pharmaceutical compositions.
Latest Patents
One of Edwin Amoro's latest patents focuses on an "Apparatus and method for cryogranulating a pharmaceutical composition." This innovative system features improved dispenser assemblies designed for the manufacturing of frozen pellets of pharmaceutical substances in a fluid medium. The methods outlined in this patent detail the cryogranulation of pharmaceutical substances, particularly those that include biodegradable materials such as proteins, peptides, and nucleic acids. The dispenser assembly is specifically engineered to work with suspensions or slurries of these compositions, enhancing the physical characteristics of the cryopellets formed while minimizing product loss during processing.
Career Highlights
Edwin Amoro is currently associated with Mannkind Corporation, where he applies his expertise in pharmaceutical innovations. His work has been pivotal in developing technologies that improve the efficiency and effectiveness of pharmaceutical manufacturing processes.
Collaborations
Throughout his career, Edwin has collaborated with esteemed colleagues, including Karel Vanackere and Michael A White. These partnerships have contributed to the advancement of his research and the successful implementation of his inventions.
Conclusion
Edwin Amoro stands out as a significant figure in the realm of pharmaceutical innovation, particularly in cryogranulation technology. His contributions continue to shape the future of pharmaceutical manufacturing, ensuring better outcomes for various medical applications.